Shijiazhuang Yiling Pharmaceutical Co., Ltd.
002603
Kedudukan dalam Saham
#4251
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and... Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for cardiovascular and cerebrovascular, respiratory, endocrine, neurological, digestive, immune, and urinary diseases, diabetes mellitus, oncology, sleep-improving, and anti-aging. The company also provides dietary supplements, disinfection products, personal protective equipment, as well as formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.
Harga Saham
$2.23
Modal Pasaran
$3.72B
Perubahan (1 hari)
0.26%
Perubahan (1 tahun)
-8.93%
Negara
CN
Perdagangan Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603)
Kategori
Healthcare
Pendapatan untuk Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603)
Pendapatan pada Jun 2026 TTM: $246.26M
Menurut laporan kewangan terkini Shijiazhuang Yiling Pharmaceutical Co., Ltd., pendapatan semasa syarikat ialah $246.26M. Pada tahun 2023, syarikat memperoleh pendapatan sebanyak $237.93M, penurunan berbanding pendapatan pada tahun 2022 yang berjumlah $403.11M. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Shijiazhuang Yiling Pharmaceutical Co., Ltd. dari 2008 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun | Pendapatan | Ubah |
|---|---|---|
| 2026 (TTM) | $246.26M | -324.63% |
| 2024 | $-109.63M | -146.08% |
| 2023 | $237.93M | -40.98% |
| 2022 | $403.11M | 64.90% |
| 2021 | $244.45M | 12.26% |
| 2020 | $217.75M | 114.19% |
| 2019 | $101.66M | -0.25% |
| 2018 | $101.91M | 3.87% |
| 2017 | $98.11M | 8.63% |
| 2016 | $90.32M | 17.44% |
| 2015 | $76.90M | 16.02% |
| 2014 | $66.28M | 38.96% |
| 2013 | $47.70M | 37.56% |
| 2012 | $34.68M | -58.95% |
| 2011 | $84.47M | 51.19% |
| 2010 | $55.87M | 7.65% |
| 2009 | $51.90M | 145.52% |
| 2008 | $21.14M | 0.00% |
Pendapatan untuk syarikat atau pesaing serupa
| Syarikat | Pendapatan | Perbezaan Pendapatan | Negara |
|---|---|---|---|
| $1.35B | 448.16% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| $26.37M | -89.29% |
US
|
